Privi Speciality Chemicals growth ratios

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
+22.0%+19.9%+9.0%
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
+42.5%+39.6%+74.8%
+56.1%+59.6%+160.3%
+71.4%+93.6%+348.5%
+75.2%+95.9%+348.3%
+13.6%+19.1%−2.0%
+28.9%+18.8%+12.6%
+95.7%−20.7%+627.0%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

PRIVISCL₹3,296.30

Privi Speciality Chemicals Ltd.

· Chemicals
₹ CrorePeersAARTIINDRAINRALLISRCFNFLREFEXNEOGENLXCHEMMcap ₹12,876 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Revenue Growth—+9.0+19.9+22.0—
EBITDA Growth—+74.8+39.6+42.5—
EBIT Growth—+160.3+59.6+56.1—
Net Income Growth—+348.5+93.6+71.4—
EPS Growth—+348.3+95.9+75.2—
Total Assets Growth—-2.0+19.1+13.6—
Total Equity Growth—+12.6+18.8+28.9—
Cash from Operations Growth—+627.0-20.7+95.7—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.